Literature DB >> 25597198

Improving the management of asthma in adults in primary care.

Wendy Funston1, Bernard Higgins.   

Abstract

Studies in adult patients have suggested that 30% of those diagnosed with asthma do not have the condition and it is likely that the diagnosis is missed in many others. Initial clinical assessment should explore symptoms of wheeze, breathlessness, chest tightness and cough. The probability of asthma is increased if more than one of these symptoms is present and particularly if symptoms are worse at night and in the early morning or are exacerbated by triggers such as exercise, allergen exposure, cold air or drugs. The BTS/SIGN guideline advocates spirometry after taking the history. If airflow obstruction is present, a trial of treatment can commence, but a firm diagnosis also requires a symptomatic response and an improvement in the measured airflow obstruction. The FeNO level correlates well with airway inflammation, and is therefore a good indicator of asthma and in particular of the likely response to inhaled corticosteroids. The test is especially useful for patients with suggestive symptoms but normal spirometry. The cornerstone of asthma monitoring is a structured clinical review conducted in primary care on at least an annual basis. Health outcomes are improved by education in self-management, incorporating written personalised asthma action plans. Checking concordance with existing therapies and inhaler technique before escalating treatment is an important part of improving the pharmacological management of asthma. Any patient prescribed more than one short-acting bronchodilator device a month should be identified and have their asthma assessed urgently and measures taken to improve overall control.

Entities:  

Mesh:

Year:  2014        PMID: 25597198

Source DB:  PubMed          Journal:  Practitioner        ISSN: 0032-6518


  5 in total

1.  Factors associated with high short-acting β2-agonist use in urban children with asthma.

Authors:  Arlene M Butz; Jean Ogborn; Shawna Mudd; Jeromie Ballreich; Mona Tsoukleris; Joan Kub; Melissa Bellin; Mary Elizabeth Bollinger
Journal:  Ann Allergy Asthma Immunol       Date:  2015-03-31       Impact factor: 6.347

2.  Epigallocatechin gallate improves airway inflammation through TGF‑β1 signaling pathway in asthmatic mice.

Authors:  Lishen Shan; Xinyuan Kang; Fen Liu; Xuxu Cai; Xiaohua Han; Yunxiao Shang
Journal:  Mol Med Rep       Date:  2018-06-18       Impact factor: 2.952

Review 3.  Bringing asthma care into the twenty-first century.

Authors:  Kjell Larsson; Hannu Kankaanranta; Christer Janson; Lauri Lehtimäki; Björn Ställberg; Anders Løkke; Kristian Høines; Klaus Roslind; Charlotte Suppli Ulrik
Journal:  NPJ Prim Care Respir Med       Date:  2020-06-05       Impact factor: 2.871

4.  Assessment of Clinical Diagnostic Efficacy of Pulmonary Function Test Based on DBN-SVM of Pediatric Asthma and Cough Variant Asthma.

Authors:  Hanyi Li; Xinmei Zhang; Qijun Zhao; Xiang Bai; Shuying Wang
Journal:  Comput Intell Neurosci       Date:  2022-03-31

5.  The Myth of Mild: Severe Exacerbations in Mild Asthma: An Underappreciated, but Preventable Problem.

Authors:  Alan Kaplan
Journal:  Adv Ther       Date:  2021-01-20       Impact factor: 3.845

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.